12 research outputs found
Valorization of Cistus ladanifer and Erica arborea shrubs for fuel: Wood and bark thermal characterization
As a form of upgraded biomass characterized by its high energy density, low production costs, and low process energy requirements, wood pellets are an environmentally friendly fuel allowing for carbon neutral heating with high energy efficiency. In this work, the suitability of a valorization of the woods from the two most representative shrub species from the Iberian Peninsula (namely Cistus ladanifer and Erica arborea) for heating has been assessed. Whereas Erica arborea met the requirements of ISO 17225-2:2014 for ENplus-B class (the calorific content for both wood and bark was high and not significantly different, and the ash content was permissible for specimens with branch diameter =2, 8 cm), Cistus ladanifer was in the limit of the normative and only met the requirements in terms of acceptable ash percentage (1, 9%) and heating value (19 kJ·g-1) for old specimens with branch diameters > 3, 4 cm. Consequently, while the harvest of E. arborea for its use as fuel does not need to be selective, that of C. ladanifer should be limited to the most robust specimens and foliage should be avoided
Mediterranean shrublands as carbon sinks for climate change mitigation: new root-to-shoot ratios
Shrublands play an important role in the reduction of atmospheric CO2 and contribute to the mitigation of the effects of climate change, due to their ability to act as carbon sinks and the large expanses of land involved. Two of the most representative shrub species in the Iberian Peninsula, Cistus ladanifer L. and Erica arborea L., were studied in terms of biomass distribution and carbon and nitrogen contents in the different fractions. With a view to fast and cost-effective estimation of radical biomass, a new procedure for easy root-to-shoot calculation based on vibrational data was proposed, resulting in an excellent agreement with the values obtained from conventional direct belowground and aerial biomass measurements: 0.23 for C. ladanifer and 0.54 for E. arborea. Carbon sequestration, estimated at 45 and 73 t CO2 eq·ha-1 for C. ladanifer and E. arborea, respectively, was subsequently determined. Since these values are substantially higher than those of other shrubs, these two key species can be deemed particularly promising for ecological restoration and carbon offsetting
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3â5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variantâs success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes. © 2021, The Author(s), under exclusive licence to Springer Nature Limited
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Background: Myeloid-derived suppressor cells (MDSCs) are relevant in prostate cancer microenvironment
collaborating in tumor development. The main tumor marker used in this disease, prostate-specific antigen
(PSA), does not provide information related to this tumor microenvironment. Cancer cells secrete exosomes
carrying bioactive molecules contributing to MDSCs recruitment and induction. The aim of this study was to
characterize the perioperative changes of exosomal cytokines relevant in MDSCs recruitment induced by pros-
tatectomy in prostate cancer patients.
Methods: Blood was drawn from 26 early-stage prostate cancer patients before and after radical prostatectomy
and from 16 healthy volunteers. Serum exosomes were separated by precipitation. Cytokines related with MDSC
cell recruitment and activation CCL2, CXCL2, CXCL5, CXCL8, CXCL12, MIF, S100A9 and TGF-Ă were measured
in serum and serum-derived exosomes using immunometric assays.
Results: All cytokines were detected both in serum and exosomes, except for CXCL12, which was detected only in serum. Exosomes were enriched specially in MIF, TGF-Ă and CXCL2. Presurgical MIF levels in exosomes correlated negatively with serum PSA. Also, presurgical TGF-Ă decreased both in serum and exosomes as Gleason score rises. PatientsÌ presurgical exosomes had increased CCL2, CXCL5 and TGF-Ă levels than exosomes from healthy controls. These differences were not observed when cytokines were analyzed in serum, except for TGF-Ă.Cytokine levels of CCL2, CXCL5 decreased in patientsâ postsurgical exosomes, while TGF-Ă further increased. On the contrary, S100A9 levels were lower in patientsÌ presurgical exosomes but increased after radical prostatectomy.
Conclusions: Blood exosomal content in cytokines constitute an attractive source to evaluate MDSCs immuno-
modulators providing additional information related to tumor microenvironment in prostate cance
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Background: Myeloid-derived suppressor cells (MDSCs) are relevant in prostate cancer microenvironment
collaborating in tumor development. The main tumor marker used in this disease, prostate-specific antigen
(PSA), does not provide information related to this tumor microenvironment. Cancer cells secrete exosomes
carrying bioactive molecules contributing to MDSCs recruitment and induction. The aim of this study was to
characterize the perioperative changes of exosomal cytokines relevant in MDSCs recruitment induced by pros-
tatectomy in prostate cancer patients.
Methods: Blood was drawn from 26 early-stage prostate cancer patients before and after radical prostatectomy
and from 16 healthy volunteers. Serum exosomes were separated by precipitation. Cytokines related with MDSC
cell recruitment and activation CCL2, CXCL2, CXCL5, CXCL8, CXCL12, MIF, S100A9 and TGF-Ă were measured
in serum and serum-derived exosomes using immunometric assays.
Results: All cytokines were detected both in serum and exosomes, except for CXCL12, which was detected only in serum. Exosomes were enriched specially in MIF, TGF-Ă and CXCL2. Presurgical MIF levels in exosomes correlated negatively with serum PSA. Also, presurgical TGF-Ă decreased both in serum and exosomes as Gleason score rises. PatientsÌ presurgical exosomes had increased CCL2, CXCL5 and TGF-Ă levels than exosomes from healthy controls. These differences were not observed when cytokines were analyzed in serum, except for TGF-Ă.Cytokine levels of CCL2, CXCL5 decreased in patientsâ postsurgical exosomes, while TGF-Ă further increased. On the contrary, S100A9 levels were lower in patientsÌ presurgical exosomes but increased after radical prostatectomy.
Conclusions: Blood exosomal content in cytokines constitute an attractive source to evaluate MDSCs immuno-
modulators providing additional information related to tumor microenvironment in prostate cance
Immunocompromised patients with acute respiratory distress syndrome : Secondary analysis of the LUNG SAFE database
The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Background: Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season. The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted to the ICU. Methods: A prospective multicenter observational cohort study was based on data from the GETGAG/SEMICYUC registry (2009â2015) collected by 148 Spanish ICUs. All patients admitted to the ICU in which diagnosis of influenza A (H1N1)pdm09 virus infection had been established within the first week of hospitalization were included. Patients were classified into two groups according to the time at which the diagnosis was made: early (within the first 2 days of hospital admission) and late (between the 3rd and 7th day of hospital admission). Factors associated with a delay in diagnosis were assessed by logistic regression analysis. Results: In 2059 ICU patients diagnosed with influenza A (H1N1)pdm09 virus infection within the first 7 days of hospitalization, the diagnosis was established early in 1314 (63.8 %) patients and late in the remaining 745 (36.2 %). Independent variables related to a late diagnosis were: age (odds ratio (OR)â=â1.02, 95 % confidence interval (CI) 1.01â1.03, Pâ<â0.001); first seasonal period (2009â2012) (ORâ=â2.08, 95 % CI 1.64â2.63, Pâ<â0.001); days of hospital stay before ICU admission (ORâ=â1.26, 95 % CI 1.17â1.35, Pâ<â0.001); mechanical ventilation (ORâ=â1.58, 95 % CI 1.17â2.13, Pâ=â0.002); and continuous venovenous hemofiltration (ORâ=â1.54, 95 % CI 1.08â2.18, Pâ=â0.016). The intra-ICU mortality was significantly higher among patients with late diagnosis as compared with early diagnosis (26.9 % vs 17.1 %, Pâ<â0.001). Diagnostic delay was one independent risk factor for mortality (ORâ=â1.36, 95 % CI 1.03â1.81, Pâ<â0.001). Conclusions: Late diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection is associated with a delay in ICU admission, greater possibilities of respiratory and renal failure, and higher mortality rate. Delay in diagnosis of flu is an independent variable related to death
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
Aims:
Hypertensive disorders occur in women with peripartum cardiomyopathy (PPCM). How often hypertensive disorders co-exist, and to what extent they impact outcomes, is less clear. We describe differences in phenotype and outcomes in women with PPCM with and without hypertensive disorders during pregnancy.
Methods:
The European Society of Cardiology PPCM Registry enrolled women with PPCM from 2012-2018. Three groups were examined: 1) women without hypertension (âPPCM-noHTNâ); 2) women with hypertension but without pre-eclampsia (âPPCM-HTNâ); 3) women with pre-eclampsia (âPPCM-PEâ). Maternal (6-month) and neonatal outcomes were compared.
Results:
Of 735 women included, 452 (61.5%) had PPCM-noHTN, 99 (13.5%) had PPCM-HTN and 184 (25.0%) had PPCM-PE. Compared to women with PPCM-noHTN, women with PPCM-PE had more severe symptoms (NYHA IV in 44.4% and 29.9%, p<0.001), more frequent signs of heart failure (pulmonary rales in 70.7% and 55.4%, p=0.002), higher baseline LVEF (32.7% and 30.7%, p=0.005) and smaller left ventricular end diastolic diameter (57.4mm [±6.7] and 59.8mm [±8.1], p<0.001). There were no differences in the frequencies of death from any cause, re-hospitalization for any cause, stroke, or thromboembolic events. Compared to women with PPCM-noHTN, women with PPCM-PE had a greater likelihood of left ventricular recovery (LVEFâ„50%) (adjusted OR 2.08 95% CI 1.21-3.57) and an adverse neonatal outcome (composite of termination, miscarriage, low birth weight or neonatal death) (adjusted OR 2.84 95% CI 1.66-4.87).
Conclusion:
Differences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM
Death in hospital following ICU discharge : insights from the LUNG SAFE study
Altres ajuts: Italian Ministry of University and Research (MIUR)-Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic); Science Foundation Ireland Future Research Leaders Award; European Society of Intensive Care Medicine (ESICM), Brussels; St Michael's Hospital, Toronto; University of Milan-Bicocca, Monza, Italy.Background: To determine the frequency of, and factors associated with, death in hospital following ICU discharge to the ward. Methods: The Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE study was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted across 459 ICUs from 50 countries globally. This study aimed to understand the frequency and factors associated with death in hospital in patients who survived their ICU stay. We examined outcomes in the subpopulation discharged with no limitations of life sustaining treatments ('treatment limitations'), and the subpopulations with treatment limitations. Results: 2186 (94%) patients with no treatment limitations discharged from ICU survived, while 142 (6%) died in hospital. 118 (61%) of patients with treatment limitations survived while 77 (39%) patients died in hospital. Patients without treatment limitations that died in hospital after ICU discharge were older, more likely to have COPD, immunocompromise or chronic renal failure, less likely to have trauma as a risk factor for ARDS. Patients that died post ICU discharge were less likely to receive neuromuscular blockade, or to receive any adjunctive measure, and had a higher pre- ICU discharge non-pulmonary SOFA score. A similar pattern was seen in patients with treatment limitations that died in hospital following ICU discharge. Conclusions: A significant proportion of patients die in hospital following discharge from ICU, with higher mortality in patients with limitations of life-sustaining treatments in place. Non-survivors had higher systemic illness severity scores at ICU discharge than survivors. Trial Registration: ClinicalTrials.gov NCT02010073